Add To My Watchlist
View My Watchlist

Green Zone Power Rating: 75 Bullish

Action to take: BUY
Bullish stocks are expected to outperform the market by 2X over the next 12 months.
75
Price Based
Momentum
59
Size
6
Volatility
69
Fundamental Based
Value
45
Quality
93
Growth
96
Positive Factors (Top 20%)
Quality: High-quality stocks tend to outperform low-quality stocks.
Growth: High-growth stocks tend to outperform low-growth stocks.
Negative Factors (Bottom 20%)
Size: Stocks of the largest companies tend to lag the returns of otherwise equally-rated smaller companies.
Collapse Detail
NASDAQ%3AROST charts & data provided by TradingView

Latest Insights on ROST

commercial real estate trade SLG Ghosts of the Alexandria Hotel
by Financial Markets Group March 2, 2024 News
Mega CRE defaults are not just confined to LA’s 14th District...
earnings Rambus Enterprise Products Partners american eagle abercrombie MTN MRVL lzb swbi AYI MU PSMT AZZ BLK PEP TXN JNJ GILD TER CSCO AMAT Chewy Toll Brothers Expedia Fiserv RYAN CWC CALM LAKE Earnings mtdr Target TGT Walmart WMT tech earnings Your Power Ratings Guide to Earnings as Stocks Pop (and Drop)
by Chad Stone March 1, 2024 Money & Markets Daily
It's been a wild earnings season. Here's how you can use Green Zone Power Ratings to analyze a stock's prospects around quarterly calls.
interest rates dividends What the End of Fed Rate Hikes Means for Stocks
by Financial Markets Group April 29, 2023 Investing
By now, it’s very well possible GDP has already slipped into reverse. We won’t know until the Commerce Department’s Q2 report is released in late July. In the interim, there’s an important question to be asked: Is a recession bullish or bearish for stocks?
big data stock to buy SIMO Super Micro Computer Inc. stock SMCI MicroStrategy stock MSTR 1 “High-Risk” Data Co. Should Analyze Its Own Numbers First
by Matthew Clark February 1, 2023 Money & Markets Daily
Data analytics is big business, but this company is struggling to match its overvalued status.
Medical Tech Power Stock Simplifies Surgery, Leads Industry
by Matthew Clark October 4, 2022 Investing
Demand for non invasive medical tools is on the rise. This medical technology stock will continue its strong performance in 2022 and beyond.